Abstract
Molecular screening of at-risk relatives belonging to families with documented pheochromocytoma/paraganglioma (PPGL) with germline mutation is known to be essential for early diagnosis and treatment. There are, however, 111 index cases reported with mutation in the TMEM127 gene and only 15% of them had a positive family history. Tracing relatives at risk is, still, very little evaluated i…